Compare SA & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SA | BHC |
|---|---|---|
| Founded | 1979 | N/A |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.5B |
| IPO Year | 2004 | 1996 |
| Metric | SA | BHC |
|---|---|---|
| Price | $30.26 | $5.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $65.00 | $8.33 |
| AVG Volume (30 Days) | 1.1M | ★ 1.5M |
| Earning Date | 05-13-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | ★ $8,724,000,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.77 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.40 | $4.28 |
| 52 Week High | $40.06 | $8.69 |
| Indicator | SA | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 51.44 | 49.11 |
| Support Level | $27.94 | $4.93 |
| Resistance Level | $31.26 | $7.22 |
| Average True Range (ATR) | 1.72 | 0.18 |
| MACD | 0.35 | 0.08 |
| Stochastic Oscillator | 77.18 | 60.87 |
Seabridge Gold Inc is a development stage company involved in the exploration and development of gold properties situated in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, the Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.